Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
10.85
-0.18 (-1.63%)
At close: Dec 5, 2025, 4:00 PM EST
10.88
+0.03 (0.28%)
After-hours: Dec 5, 2025, 7:56 PM EST
Omeros Employees
Omeros had 202 employees as of December 31, 2024. The number of employees increased by 4 or 2.02% compared to the previous year.
Employees
202
Change (1Y)
4
Growth (1Y)
2.02%
Revenue / Employee
n/a
Profits / Employee
-$599,797
Market Cap
769.27M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
OMER News
- 5 days ago - Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros' Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906) - Business Wire
- 19 days ago - Omeros Corporation (OMER) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Omeros Corporation Reports Third Quarter 2025 Financial Results - Business Wire
- 25 days ago - Omeros Corporation to Announce Third Quarter Financial Results on November 13, 2025 - Business Wire
- 7 weeks ago - Omeros: Novo Nordisk Deal Highlights MASP-3 Alternative Pathway Targeting - Seeking Alpha
- 7 weeks ago - Omeros: Novo Nordisk's Licensing Deal Sends Shares Soaring, Makes Bull Case - Seeking Alpha
- 7 weeks ago - Omeros Announces Publication Highlighting Survival Benefits in TA-TMA Patients Treated with Narsoplimab Versus a Well-Matched External Control Group - Business Wire
- 7 weeks ago - A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now? - The Motley Fool